BioSpace News Archive

Business

Orexo Q3 2021 Interim Report

Steady progression on our journey to build a broader and stronger Orexo

November 3, 2021
·
3 min read
Drug Development

CytoDyn Reports Preliminary Results from First Five Patients in Phase 2 NASH Open Label Leronlimab Trial. Lower Fatty Deposits in All 5 Patients by as Much as 45% and Lower Fibrosis in 4 Patients by as Much as 10% Compared to Baseline.

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced preliminary results from the first five patients treated with leronlimab in its Phase 2 trial for NASH open label.

November 3, 2021
·
13 min read
Business

Amarin Reports Third Quarter 2021 Financial Results and Provides Business Update

Amarin Corporation plc, announced financial results for the third quarter and nine months ended September 30, 2021 and provided an update on Company operations.

November 3, 2021
·
32 min read
Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced ambitious commitments to address two of today’s greatest global crises—access to medicines and climate change—tied to its recently issued $5 billion sustainability-linked bond.

November 3, 2021
·
4 min read
Plaque Psoriasis Treatment Market: The TNF-α inhibitors segment dominated the market

Plaque psoriasis is the most common type of psoriasis and accounts for 80% to 90% cases of total psoriasis. Plaque psoriasis is an autoimmune condition, wherein thick, red patches appear on the skin.

November 3, 2021
·
5 min read
Worldwide Laboratory Equipment Services Market Detailed Analysis and Accurate Forecast to 2025

The rising number of asset management companies is creating considerable growth opportunities for the global laboratory equipment services market, which as per the report is likely to exhibit a strong CAGR between 2017 and 2025.

November 3, 2021
·
4 min read
Blue Biotechnology Market: Increase in the adoption of biological products to drive the market

Biotechnology utilizes living organisms or parts of living organisms and biological systems to create or develop different products.

November 3, 2021
·
6 min read
Long-Acting Insulin Emerges as User-friendly Drug Delivery Method, Demand to Grow by 9.4% CAGR through 2031

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the newly released data by Fact.MR, the long-acting insulin market is projected to expand at 9.4% CAGR between 2021 and 2031.

November 3, 2021
·
8 min read
Retrievable Stents Market | Latest Trends and Future Scope Analysis Report

Retrievable stents are class II medical devices which are used to remove the blood clot from the artery.

November 3, 2021
·
6 min read
Business

Medivir AB - Interim Report January - September 2021

Positive MIV-818 data presented at ESMO. New positive data and renegotiated agreement for remetinostat.

November 3, 2021
·
7 min read